HTG Molecular Diagnostics, Inc
HTGMDelisted Jul 10, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001169987
HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.
Holders of 5% or more of HTGM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of HTG Molecular Diagnostics, Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of HTG Molecular Diagnostics, Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
22 Schedule 13D and 13G filings on HTG Molecular Diagnostics, Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2023 | Lytton Laurence W | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Samjo Capital LLC | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2023 | Cowen Prime Advisors LLC | 13GOld format | – | – | – | SEC |
| Dec 7, 20226:01 AM ET | BitNile Holdings, Inc. | 13D/AOld format | – | – | – | SEC |
| Dec 2, 20224:30 PM ET | BitNile Holdings, Inc. | 13D/AOld format | – | – | – | SEC |
| Aug 5, 20226:01 AM ET | BitNile Holdings, Inc. | 13DOld format | – | New | – | SEC |
| Jul 28, 2022 | Hewlett Fund LP | 13G/AOld format | – | – | – | SEC |
| Jul 18, 2022 | L5 Capital Inc. | 13G/AOld format | – | – | – | SEC |
| Jun 29, 2022 | L5 Capital Inc. | 13GOld format | – | New | – | SEC |
| Mar 31, 2022 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Feb 15, 2022 | Lytton Laurence W | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Nantahala Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Cowen Prime Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 8, 2022 | Samjo Capital LLC | 13G/AOld format | – | – | – | SEC |
| Jan 4, 2022 | Hewlett Fund LP | 13G/AOld format | – | – | – | SEC |
| Jun 30, 2021 | Hewlett Fund LP | 13GOld format | – | New | – | SEC |
| Jun 7, 2021 | Hirschman Orin | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Nantahala Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Lytton Laurence W | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Stonepine Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Samjo Capital LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell HTG Molecular Diagnostics, Inc shares.
No Form 144 notices for HTG Molecular Diagnostics, Inc are on file.